Status:
TERMINATED
Povidone-Iodine Rinses in the Management of COVID-19
Lead Sponsor:
St. Paul's Hospital, Canada
Conditions:
Covid19
Eligibility:
All Genders
19+ years
Phase:
EARLY_PHASE1
Brief Summary
The aim of this study is to determine if Povidone iodine (PVP-I) rinses and throat gargles or a PVP-I gel forming nasal spray compared to a placebo (a treatment that has no physical effect to a person...
Detailed Description
The proposed study is a prospective randomized double blinded placebo-controlled study of 6-weeks in duration. Patients who have tested positive and diagnosed with COVID-19 within the previous 72 h an...
Eligibility Criteria
Inclusion
- 19 years or older
- Patients diagnosed with laboratory-confirmed SARS-CoV-2 and the development of COVID-19 compatible symptoms within the last 72 hours before enrolment
- Do not require hospitalization
Exclusion
- Sinonasal tumor
- Hypersensitivity to iodine or betadine
- History of thyroid disorder including thyroid cancer, hyperthyroidism and hypothyroidism
- Use of medications for thyroid disorders including thyroxine and carbimazole
- Current use of topical iodine or betadine for another reason
- Participating in any study with therapies directed at COVID-19 that could influence our results
- Are pregnant or breastfeeding
Key Trial Info
Start Date :
January 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04449965
Start Date
January 19 2021
End Date
August 16 2021
Last Update
July 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z1Y6